Finanical Statements
Glaxo Smith Kline (BIOC.CA) Reports 6 Months Standalone Results
Published at 13 August 2026 at 11:00Glaxo Smith KlineRelated stock:Glaxo Smith Kline stockAll Glaxo Smith Kline disclosures
Disclosure summary
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Standalone Period : From 01/01/2026 To 30/06/2026
Net Profit : 67,466,432
F/S Standalone Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 71,331,341
Audit Status : Reviewed
Source : Glaxo Smith Kline
The Financial Statements in Arabic (6,219 KB)
The Financial Statements in English (6,519 KB)
ISIN Code : EGS38171C012
Currency : EGP
F/S Standalone Period : From 01/01/2026 To 30/06/2026
Net Profit : 67,466,432
F/S Standalone Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 71,331,341
Audit Status : Reviewed
Source : Glaxo Smith Kline
The Financial Statements in Arabic (6,219 KB)
The Financial Statements in English (6,519 KB)